Adele Cirone Oliva
2 additional roles and seats, 8 additional attributed investments
Every relationship, signal and contact on this record, with the source on each.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
Nothing material in the last 365 days.
Roles
- 1315 Capital ManagerFeb 1, 2015 to present · “Schedule A: OLIVA, ADELE, CIRONE, MANAGER, since 02/2015, ownership E, control person Y”Fact Form ADV
- Quaker Partners Management L.P. MemberJan 1, 2011 to present · “Schedule A: OLIVA, ADELE, CIRONE, MEMBER, since 01/2011, ownership C, control person Y”Fact Form ADV
Investments attributed to this person
| Company | Round | Investor | Attribution | Date | Source |
|---|---|---|---|---|---|
| Onkos Surgical | Form D equity offering · $37.2M | 1315 Capital | strongly supported · board | Sep 13, 2021 | Inference sec.gov |
| Onkos Surgical | Form D equity offering · $7.6M | 1315 Capital | strongly supported · board | Apr 30, 2020 | Inference sec.gov |
| Colorescience | Form D equity offering · $3.0M | 1315 Capital | strongly supported · board | Feb 10, 2020 | Inference sec.gov |
Board seats and vehicles
- Onkos Surgical board seat on a deal Sep 13, 2021 Inference
- Colorescience board seat on a deal Feb 10, 2020 Inference
- Encore Dermatology board seat on a deal Apr 15, 2019 Inference
Timeline
- Sep 13, 2021Form D equity offering in Onkos Surgical (1315 Capital)
- Apr 30, 2020Form D equity offering in Onkos Surgical (1315 Capital)
- Feb 10, 2020Form D equity offering in Colorescience (1315 Capital)
- Feb 1, 2015Joined 1315 Capital as Manager
- Jan 1, 2011Joined Quaker Partners Management L.P. as Member
Relationships across DFX
on 1 other DFX graph
Adele Cirone Oliva is the same institution as 1 record in Private Equity.
The joined record opens with the product, beside every other relationship on this page.
Checking your plan…